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Abstract
The isotropic metaphase actin cortex progressively polarizes as the
anaphase spindle elongates during mitotic exit. This involves the
loss of actomyosin cortex from opposing cell poles and the accu-
mulation of an actomyosin belt at the cell centre. Although these
spatially distinct cortical remodelling events are coordinated in
time, here we show that they are independent of each other. Thus,
actomyosin is lost from opposing poles in anaphase cells that lack
an actomyosin ring owing to centralspindlin depletion. In examin-
ing potential regulators of this process, we identify a role for
Aurora B kinase in actin clearance at cell poles. Upon combining
Aurora B inhibition with centralspindlin depletion, cells exiting
mitosis fail to change shape and remain completely spherical.
Additionally, we demonstrate a requirement for Aurora B in the
clearance of cortical actin close to anaphase chromatin in cells
exiting mitosis with a bipolar spindle and in monopolar cells forced
to divide while flat. Altogether, these data suggest a novel role for
Aurora B activity in facilitating DNA-mediated polar relaxation at
anaphase, polarization of the actomyosin cortex, and cell division.
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Introduction
Cell division involves the segregation of genetic material and cellular
components into two daughter cells. Cytokinesis is the final step in
this process, whereby an actomyosin ring constricts to cleave the cell
into two. This process begins with anaphase cell elongation, as spher-
ical cells exiting mitosis adopt an ellipsoid shape. Concomitantly, as
the DNA begins to separate and reach the poles, there is a break in
the symmetry of the uniform spherical cortical actomyosin network
as the cortical actomyosin network softens at the poles and stiffens
and constricts at the cell centre. The timely execution of this process
requires extensive crosstalk between the spindle and the overlying
cortical actomyosin network and is essential for the accurate segrega-
tion of sister chromatids at division (Ramkumar & Baum, 2016).
Multiple pathways have been shown to be involved in this cross-
talk and in the regulation of cytokinesis in both time and space.
Although these events differ between cell types and across evolu-
tion, pioneering work from Ray Rappaport provided a crucial frame-
work for understanding this process (Rappaport, 1996). He
demonstrated that overlapping antiparallel microtubule from oppos-
ing spindle poles position the cleavage furrow—helping to ensure
that the actomyosin ring bisects the spindle.
As this contractile actomyosin ring is specified, anaphase cells
elongate along their long cell axis. This change in shape has often
been attributed to the effects of the gradient in cortical contractility
induced via actomyosin ring formation (Pollard, 2010; Turlier et al,
2014). However, it has long been appreciated that polar relaxation
itself may play a critical part in this process (Wolpert, 1960). In fact,
the softening of cell poles is a likely pre-requisite for the division of
animal cells which have undergone prior cortical stiffening during
the process of mitotic rounding (Taubenberger et al, 2020). In addi-
tion, polar re-spreading has been shown to be sufficient to drive cell
division in some cells that lack contractile components of the cleav-
age furrow (Kanada et al, 2005; Dix et al, 2018). While the pathways
involved in this process of polar relaxation are not yet clear, recent
work has suggested a role for DNA-dependent cues in polar relax-
ation (Kiyomitsu & Cheeseman, 2012; Rodrigues et al, 2015). These
data point towards a role for the advancing chromosomes in soften-
ing cell poles in early anaphase as an aid to division. Two pathways
have been suggested to regulate polar relaxation. A chromatin-based
Ran-GTP gradient (Kiyomitsu & Cheeseman, 2012) has been
proposed to act via importin to limit the accumulation of Anillin at
cell poles. In addition, a kinetochore-associated pool of Sds22/PP1
has been proposed to dephosphorylate cortical ERM proteins (Rodri-
gues et al, 2015). Since ERM proteins link actin cytoskeleton to the
membrane, localized ERM dephosphorylation at cell poles was
proposed to de-couple the actomyosin network from the plasma
membrane to reduce the mechanical rigidity of the actomyosin
network at the poles (Kunda et al, 2012). The activation of Arp2/3 at
the polar cortex could assist this process by driving polar cell re-
spreading in some systems (Kanada et al, 2005; Dix et al, 2018).
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Due to the dynamic nature of the changes in cell shape and
cytoskeletal organization during mitotic exit, it is important that these
spatially distinct processes—polar relaxation, contractile ring specifi-
cation and furrowing, be coordinated. While it is not understood
precisely how this is achieved, Aurora B, the core member of the
chromosome passenger complex (CPC), likely plays a role in this
process. It has been implicated in multiple events at mitotic exit (Car-
mena et al, 2015; Afonso et al, 2016; Liu & Pellman, 2020), including
in cell and nuclear division (Carmena et al, 2015; Petersen & Hagan,
2003; Afonso et al, 2014; Roubinet et al, 2021), and in spindle assem-
bly checkpoint function (Krenn & Musacchio, 2015). Midzone local-
ized Aurora B has been shown to regulate the oligomerization and
accumulation of centralspindlin proteins, which guide the construc-
tion of the contractile ring during cytokinesis (Basant et al, 2015;
Adriaans et al, 2019), and to assist in the final steps of abscission
(Guse et al, 2005; Ahonen et al, 2009; Carmena, 2012). In addition,
the kinase appears to function at a distance, since a gradient of
Aurora B phosphorylation is thought to regulate the separation of
DNA during anaphase and to guide the progressive formation of the
nuclear envelope soon after (Fuller et al, 2008; Afonso et al, 2014;
Liu & Pellman, 2020). The ability of Aurora B to function in so many
distinct processes is likely due to its dynamic localization. Thus, at
the metaphase-anaphase transition, Aurora B undergoes a sudden
change in localization from centromeres to the developing spindle
midzone and the equatorial cortex (Van Der Horst & Lens, 2014). It is
clear from these studies that, despite system specific differences in its
function, Aurora B helps to choreograph many of the dramatic
changes in cell organization that accompany mitotic exit.
In this paper we identify an additional role for Aurora B in polar
relaxation in human cells leaving mitosis. Strikingly, this appears to
be independent of Aurora B’s role in midzone stabilization and
centralspindlin activity, and appears to be based on a requirement
of Aurora B for chromatin-based cortical remodelling during
anaphase. These data lead us to propose that Aurora B coordinates
the softening of the cortical cytoskeleton at cell poles close to
advancing chromatin and the enhancement of midzone actomyosin
ring formation and contraction to ensure a robust coupling of
anaphase spindle elongation and cytokinesis.
Results and Discussion
Centralspindlin proteins are key players in regulating cytokinesis
(White & Glotzer, 2012). In human cells, a heterotetrametric
complex consisting of two molecules of the GTPase activating
protein, RACGAP1, and two molecules of the kinesin, MKLP1, are
recruited to the overlapping microtubules of the spindle midzone
where they stabilize the midzone and recruit ECT2, a conserved
GEF that activates RhoA to drive the local accumulation of contrac-
tile actomyosin necessary for cytokinesis (Su et al, 2011; Basant &
Glotzer, 2018). To assess the relative timing of contractile ring
assembly and polar actin clearance during mitotic exit, we
performed live cell imaging of cells depleted for RACGAP1 using
previously validated siRNAs and a HeLa cell line stably expressing
LifeAct GFP and H2B-mCherry. Cells begin to change shape at
anaphase onset. As they begin exiting mitosis, control cells elongate
along the spindle axis and constrict in width along a perpendicular
axis while the cleavage furrow is still being specified in early
anaphase (Fig 1A). These shape changes are further enhanced
following the assembly and constriction of the cleavage furrow (Fig
EV1A and B). At early stages of anaphase, these changes in cell
shape are accompanied by a modest but significant clearance of
actin filaments from cell poles (Fig 1A–E), as seen by average actin
intensity levels dipping below 1 (normalized to metaphase levels).
We observed a similar clearance of LifeAct from the poles of
RACGAP1 siRNA-treated Hela cells exiting mitosis (Fig 1A–E),
which exhibit moderate cell elongation and midzone flattening at
early anaphase (Fig EV1A and C). This was the case even though
RACGAP1 depleted anaphase cells show no sign of assembling an
actomyosin ring (Figs 1A, EV1A–C, and 4A and B), eventually lead-
ing to division failure (Fig EV1A and C).
These observations show that polar actin clearance is not an
indirect consequence of midzone actomyosin ring formation.
Instead, the data support the existence of a second pathway that
breaks cortical symmetry at the transition from spherical metaphase
to elongated anaphase cells (Kiyomitsu & Cheeseman, 2012; Rodri-
gues et al, 2015). This led us to search for additional regulators that
might cooperate with centralspindlin proteins in the polarization of
the mitotic cortical actomyosin network. For this analysis, we
focussed on Aurora B kinase, as it is a conserved regulator of cytoki-
nesis that functions as part of the chromosome passenger complex
(Carmena et al, 2015; Afonso et al, 2016).
To follow Aurora B dynamics, we endogenously tagged Aurora B
with mNeonGreen in HeLa cells using CRISPR/Cas9 and imaged
these cells as they progressed through mitosis, using red CellMask as
a marker of the plasma membrane. As observed previously, Aurora B
localizes to centromeres at metaphase in control HeLa cells. Follow-
ing satisfaction of spindle assembly checkpoint (SAC), Aurora B then
re-localizes to overlapping microtubules within the spindle midzone
and to the cleavage furrow (Fig 1F), where it remains to aid abscis-
sion (Steigemann et al, 2009). In line with previous reports showing
that Aurora B re-localization is unaffected upon knockdown of
MKLP1, another centralspindlin protein (Gruneberg et al, 2004), this
dynamic pattern of Aurora B re-localization appeared largely unal-
tered following the silencing of RACGAP1 using RNAi. Although
there was a slight reduction in levels of Aurora B::mNeonGreen at the
midzone upon RACGAP1silencing (Fig EV1D), the kinase re-
localized from the DNA to midzone microtubules and cleavage
furrow in early anaphase with similar timing in both RACGAP1 RNAi
and control cells (Fig 1F). Further, Aurora B failed to maintain its
later telophase midzone localization in the absence of RACGAP1.
The converse also proved true. Aurora B inhibition did not affect
the localization of RACGAP1, as assessed by immunofluorescence, in
cells exiting mitosis that had been fixed following treatment with
2 µM of ZM447439 (ZM), a small molecule inhibitor of the Aurora B
kinase (Ditchfield et al, 2003). Thus, in both control cells and in cells
inhibited for Aurora B activity, RACGAP1 was seen localizing to the
mitotic spindle in metaphase and to overlapping microtubules within
the midzone of the spindle in early anaphase (Fig 1G). Although the
midzone localization of RACGAP1 was maintained upon Aurora B
inhibition, there was a moderate reduction in its accumulation at the
midzone, as seen by increase in cytoplasmic levels. These data
suggest that the dynamic re-localization of Aurora B and RACGAP1
are largely independent of one another in early anaphase HeLa cells.
To better disentangle the different roles played by Aurora B, it
was important to study Aurora B localization and the impact of
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Aurora B inhibition during the very early part of anaphase in cells
that lacked a functional midzone. To do so, we forced cells to exit
mitosis with a monopolar spindle, i.e. in the absence of overlapping
microtubules by treating cells arrested in prometaphase using STLC,
an Eg5 inhibitor (Skoufias et al, 2006) with a Cdk1 inhibitor
(RO3306) (Canman et al, 2003; Hu et al, 2008). During this
“monopolar cytokinesis”, Aurora B was observed re-localizing from
centromeres to the cell cortex most distant from anaphase chro-
matin as the DNA moved poleward (Fig 2A), as previously reported
(Canman et al, 2003). This was coincident with the break in cortical
actomyosin symmetry. Thus, phosphorylated ERM proteins (pERM-
Fig 2A), which link actin filaments to the cell membrane (Bretscher
et al, 2002) and have been associated with mitotic cell shape control
(Kunda et al, 2008, 2012; Rodrigues et al, 2015), were lost from the
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cortex close to the DNA within 5 min of Cdk1 inhibitor addition.
The resulting pERM gradient (Fig 2A) strengthened over time so
that within  15 min of Cdk1 inhibitor addition most of the cells
had a well-defined cortical gradient of phosphorylated ERM localiza-
tion (Fig 2A–D).
This cortical ERM phosphorylation gradient provided an excel-
lent read-out of cortical polarization (Fig 2A–C). While pERM accu-
mulated on the cortex furthest from the DNA in control HeLa cells
undergoing a monopolar exit, cortical pERM remained isotropic in
cells treated with ZM447439, an Aurora B inhibitor (Fig 2C and D).
Since Aurora B inhibition also impacts spindle elongation (Hu et al,
2008), it was important to measure pERM levels as a function of
distance from the DNA in these experiments (Fig 2B). When taking
this into account by studying cortical polarization in cells where the
DNA succeeded in moving close to one side, pERM still failed to
polarize in the absence of Aurora B activity (Fig 2C and D). Further-
more, this function of Aurora B appears specific, since cortical
polarization was also compromised in cells exposed to another
Aurora B specific inhibitor, AZD1152 (Yang et al, 2007) and follow-
ing RNAi silencing of INCENP, another member of the chromosomal
passenger complex (Fig EV2A–D), but was unaffected by the addi-
tion of an Aurora A inhibitor (Fig EV2A and B). Interestingly, corti-
cal polarization was affected in a similar way by depletion of
MKLP2 (Fig EV2C and D), a kinesin required for Aurora B re-
localization during anaphase (Serena et al, 2015). This suggests a
role for spatial control of Aurora B activity in polarizing the cortex
at mitotic exit.
As a further test of the ability of the DNA-dependent pathway to
induce a local remodelling of the actomyosin cortex in cells lacking
Aurora B activity, we imaged cells expressing LifeAct GFP and H2B-
mCherry undergoing monopolar cytokinesis following Aurora B
inhibition with ZM447439 treatment. As observed in the context of
a bipolar mitosis (Fig 1A–C), actin was cleared from regions of the
cortex close to the anaphase chromatin in both control and
RACGAP1 siRNA-treated cells (Fig 2E and F). However, Aurora B
inhibition prevented the clearance of actin from areas of the cortex
close to the anaphase chromatin in these cells (Fig 2E and F), imply-
ing a role for Aurora B activity in DNA-dependent polarization of
cortical actomyosin in anaphase cells.
Because Aurora B aids the movement of chromatin towards the
polar cortex during both bipolar and monopolar exit, we wanted to
identify an additional method by which to test the effects of Aurora B
inhibition in cells in which the DNA was forced to closely abut the
cortex. To do so, we expressed constitutive active Rap1 (Rap1Q63E)
to flatten cells undergoing a monopolar cytokinesis. Under these
conditions, the DNA was found very close to the basal actomyosin
network allowing us to test the ability of DNA-dependent cue to clear
actomyosin during mitotic exit in the presence or absence of Aurora
B activity (Fig 3A). In these experiments, the actomyosin network
appeared to clear from the basal cortex underlying the DNA within
10 min of Cdk1 inhibition, as measured by the loss of local LifeAct
GFP (Fig 3B and C). Importantly, this clearance was prevented by
treatment of cells with the Aurora B inhibitor (Fig 3B and C).
Furthermore, when we quantified this effect in LifeAct expressing
cells 15 min after mitotic exit, actomyosin was cleared from beneath
the DNA in 51% of the control cells, while clearance was only
observed in 20% of the cells treated with the Aurora B inhibitor (Fig
EV3A and B). Similar results were seen when cells were fixed and
stained with phalloidin, a marker for filamentous actin. Again, fila-
mentous actin was cleared from the cortex close to the DNA by
15 min of forced mitotic exit in 50% of control DMSO-treated cells,
but was cleared in only 23% of ZM447439-treated cells (Fig 3D and
E). These results suggest that Aurora B activity is required for
anaphase chromatin to clear actomyosin network during mitotic exit.
Cooperative effects of Aurora B and centralspindlin on
cortical polarization
The data presented thus far support the possibility of there being
two distinct pathways that contribute to polarization of the cortex at
anaphase: one that is dependent and one independent of the central-
spindlin complex. As a test of this model, we decided to explore
how the two systems work when inhibited separately or in concert.
On their own, treatments that compromise either Aurora B or
centralspindlin had markedly different effects on the equatorial
accumulation of downstream cortical cytoskeletal proteins and their
regulators (Fig 4A and B). RACGAP1 knockdown led to a complete
loss of Anillin and pMLC from the midzone of anaphase cells.
◀ Figure 1. Actin clearance and dynamic re-localization of Aurora B in early anaphase upon centralspindlin depletion.
A Stills from time-lapse sequence of representative Hela cells expressing LifeAct GFP and H2B-mCherry exiting mitosis under different conditions, i.e. Control siRNA and
knockdown of the centralspindlin protein RACGAP1. Scale bar = 10 µm.
B High magnification view of boxed regions in (A) pseudo-coloured to show actin depletion in anaphase. Scale bar = 1 µm.
C Schematic representation for quantifying actin intensity along the cortex as in (D). Segmented line was drawn along the cortex from one equatorial region to the
other. Actin intensity across the line is plotted in (D).
D Quantification of actin intensity profile of representative siControl and siRACGAP1-treated cells shown in (A). While actin levels were uniform across the cortex at
metaphase (black line), actin is depleted from the polar regions (Blue line—segments 2–8) of both siControl and siRACGAP1-treated cells in early anaphase.
E Quantification of average actin intensity at the poles of cells at 6 min post-anaphase onset under different conditions as in (A). Despite reduced elongation, actin is
cleared from the poles in both Control cells and following RACGAP1 depletion. Data represented as mean  SD. siControl-n = 44, 0.98  0.051, siRACGAP1-n = 48,
0.99  0.041. Unpaired Welch’s t-test comparing siControl and siRACGAP1 shows no significant difference between them, P = 0.5199. One sample t-test comparing
siControl and siRACGAP1 to theoretical mean 1 (implying no change in actin compared with metaphase levels) shows significance for both treatments, with
*P = 0.0195 for siControl and *P = 0.0392 for siRACGAP1. The depletion seen for both treatments, as means are lower than 1 (red dashed line), suggests significant
clearance of actin from cell poles.
F Stills from time-lapse sequence of representative Hela cells exiting mitosis, expressing mNeonGreen Aurora B and Cell Mask to label the plasma membrane, showing
the dynamic re-localization of Aurora B from DNA to the overlapping microtubules and cleavage furrow in control siRNA cells (arrows top). Following RACGAP1
silencing, Aurora B still re-localizes from the DNA to the microtubules and furrow in the midzone in early anaphase (arrows bottom), but the microtubule localization
is lost at later stages (asterisk bottom). Scale bar = 10 µm.
G Maximum projection of 2 z slices of Hela-Cdk1as cells stained with anti-RACGAP1 antibody when treated with DMSO or 2 µM ZM447439 (ZM) at metaphase and
early anaphase, showing that RACGAP1 relocates to the spindle midzone in early anaphase even upon Aurora B inhibition. Scale bar = 10 µm.
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Figure 2. Aurora B is required for polarization of the actomyosin network in the absence of a midzone.
A Maximum projection of 2 z slices of Hela cells immunostained for Aurora B (top) and actin-membrane cross-linker pERM (bottom), showing the change in protein
localization upon Cdk1 inhibition with RO3306 (exit onset). As DNA moves to one side, Aurora B re-localizes from DNA to cortical region of the side opposite the DNA.
In addition to Aurora B, the membrane-actin cross-linker pERM also polarizes in the direction opposite to DNA localization during the course of mitotic exit. Scale
bar = 10 µm.
B Schematic representation of a cell, showing the quantification of actin and pERM along the cortex during mitotic exit. Regions 5 and 6 are cortex close to the DNA,
while regions 1 and 10 are the furthest away.
C Maximum projection of 2 z slices of Hela cells immunostained for pERM following 10 min of forced mitotic exit in presence of DMSO and 2 µM ZM447439. Cells fail
to polarize their pERM along the perimeter following Aurora B inhibition, as quantified in (D). Scale bar = 10 µm.
D Quantification of pERM intensity across the perimeter of the cells as shown in (B) where 5 and 6 represent regions closest to DNA, and 1 and 10 furthest. In DMSO-
treated cells (n = 28 cells) pERM levels increase away from the DNA. By contrast, pERM fails to polarize in cells treated with ZM447439 (n = 26 cells) during forced
mitotic exit. Data are presented as mean  SD.
E Stills of representative Hela cells expressing LifeAct GFP and H2B-mCherry at 10 min following forced mitotic exit with different treatments. Control siRNA, RACGAP1
siRNA and DMSO-treated cells show clearance of actin from the cortex close to the DNA, while ZM447439-treated cells fail to clear actin, as quantified in (F). Note,
the failure in actin accumulation following RACGAP1 depletion, asterisk. Scale bar = 10 µm.
F Quantification of actin intensity across the perimeter of the cells, measured based on distance from DNA, with 5 and 6 being closest to DNA and 1 and 10 furthest
away, as shown in schematic (B). Graph shows decrease in actin intensity closer to the DNA in siControl (n = 26), siRACGAP1 (n = 37) and Control DMSO-treated cells
(n = 38 cells), seen by average levels lower than 1 (dotted red line), while this local decrease is not seen in ZM447439-treated cells (n = 42 cells). Data are presented
as mean  SD.
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Furthermore, RACGAP1 silencing did not prevent midzone specifi-
cation in early anaphase, as seen by microtubules (Fig 4C) and Plk1
(Fig EV4A) immunostaining, although these patterns of localisation
were lost in late anaphase, leading to failure in equatorial accumula-
tion of cytoskeletal proteins. By contrast, Aurora B inhibition had
little effect on midzone protein accumulation (Fig 4A and B)—in
line with previous reports (Ahonen et al, 2009), but led to a
dispersed spindle midzone which persisted even at later anaphase
stages (Figs 4C and EV4A).
Strikingly, much stronger phenotypes were observed when both
pathways were perturbed together. In RACGAP1 RNAi cells treated
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EV4A) and the cells remained completely spherical as they exited
mitosis. Similar results were seen using live cell imaging when the
two treatments were combined in Hela cells expressing LifeAct-GFP
and H2Bmcherry. While RACGAP1 RNAi and ZM treatment had a
modest impact on cell elongation as measured by their aspect ratio
prior to furrow formation when studied in isolation (Fig 4D and E),
in combination, Aurora B inhibition and RACGAP1 silencing led to a
complete loss of anaphase cell shape changes, including cell elonga-
tion (Fig 4D and E). A similar effect was seen when Aurora B inhibi-
tion was combined with the silencing of Ect2 (Fig EV4B and C)—a
downstream target of RACGAP1 and RhoA activator (Y€uce et al,
2005; Nishimura & Yonemura, 2006).
A comparable pattern was observed when we examined the
impact of the two pathways on polar actin clearance. Again, cells
failed to clear actin from the poles following Aurora B inhibition
(Fig 5A–E), without visibly perturbing the initial assembly of the
actomyosin-based equatorial furrow (Fig 4A and B). As a result,
there was a significant delay in the timing of anaphase cell elonga-
tion in cells treated with Aurora B inhibitor relative to control cells
(Fig EV3C), suggestive of a defect in polar relaxation. These cells
eventually elongated to a similar extent to control cells as they
underwent cytokinesis.
The defect in polar anaphase actin clearance was further
enhanced by the failure of anaphase chromatin to reach close to the
actomyosin cortical network following Aurora B inhibition; and was
accentuated by the RACGAP1 knockdown (Fig 5F and G). This fail-
ure in polar relaxation upon Aurora B inhibition is likely due to a
weaker chromatin-based signal coupled with a reduction in the
elongation of the anaphase spindle. By contrast, RACGAP1 had no
significant effect on the DNA-cortex distance compared with control
siRNA-treated cells and actin was cleared from the poles during both
monopolar and bipolar mitosis (Figs 1A–C, 2E and F, and 5A–E).
We do not think that the lack of a robust penetrant phenotype
reflects an incomplete depletion of RACGAP1, as we observed a
complete loss of cortical myosin accumulation and furrow formation
in RACGAP1 silenced cells (Fig 4B).
We observed a similar synergistic effect of combining treat-
ments perturbing both RACGAP1 and Aurora B in human RPE1
cells (Fig EV5). Here again, the inhibition of Aurora B led to signif-
icant delay in cell elongation at anaphase, but did not affect furrow
formation (even though furrows eventually later regressed (Fig
EV5A and B)). While RPE1 cells can perform cytokinesis even in
the absence of the midzone pathway (Fig EV5C) (Dix et al, 2018),
when combined with Aurora B inhibition, the silencing of the
centralspindlin protein RACGAP1 (Fig EV5E and F) or its down-
stream target ECT2 (Fig EV5C and D), these cells were unable
to undergo cell shape changes at anaphase and were unable to
form a cytokinetic furrow (Fig EV5C–G). The data further
support the idea that these two pathways function in parallel
during cytokinesis.
In summary, in this study we provide evidence supporting a role
for Aurora B activity in the disassembly of the polar cortical acto-
myosin network during early anaphase that is independent of its
role in central spindle formation and in the assembly of a contractile
actomyosin ring. Further, our data suggest that Aurora B does so by
facilitating the DNA-dependent signal that previous work has impli-
cated in polar relaxation.
While important in human cells in culture, which have a large
spindle that comes into close contact with the cortex, the impor-
tance and mechanism of polar relaxation for successful completion
of cytokinesis is likely to be cell type or organism dependent. For
instance, in the Drosophila notum, cells which fail to undergo polar
relaxation complete cytokinesis, although these cells exhibit defects
during the process (Rodrigues et al, 2015). Similarly, in Hela cells, a
failure to undergo polar relaxation leads to instabilities in the
contractile ring, cell shape oscillations, but only sometimes to a fail-
ure in cytokinesis (Sedzinski et al, 2011). Conversely, while most
RPE1 cells are able to divide using adhesion-dependent polarization
without the centralspindlin complex or ECT2 function, they often
fail to furrow when treated with Aurora B inhibitor in concert.
Furthermore, when both pathways are compromised together, the
vast majority of cells fail to divide (Fig EV5G). Although Aurora B
may play a similar function in other systems, we think this will
depend on the geometrical constraints involved. Thus, we think
Aurora B is unlikely to polarize the cortex in C. elegans zygotes,
since the poles of the anaphase spindle never approach close to the
cortex in these cells.
Although we did not observe a defect in DNA-dependent clear-
ance upon Aurora A inhibition in human cells (Fig EV2A and B),
Aurora A has been identified as an aster-based signal for facilitating
polar relaxation in the C. elegans zygote (Mangal et al, 2018). Since
the two homologous Aurora kinases have a largely similar kinase
◀ Figure 3. Aurora B inhibition affects DNA-dependent actin clearance during flat monopolar cytokinesis.
A Schematic of experimental set up. Expression of dominant-negative Rap1 (RapQ63E) prevents adhesion disassembly during mitotic entry and forces cells to remain
flat during mitosis. Using Cdk1 inhibitor to induce monopolar cytokinesis in these STLC-treated cells, the reduced cell height forces anaphase DNA to come into close
proximity with the basal actomyosin network, which we measure to determine the ability of DNA-dependent cues to relax the local actomyosin network by
quantifying actin directly beneath the DNA.
B Stills from time-lapse sequence of the basal-most region of Hela cells expressing LifeAct GFP and H2B-mCherry forced to undergo flat monopolar mitotic exit. While
actin is cleared underneath the DNA in control DMSO-treated cells, it fails to be cleared around the DNA when cells are treated with Aurora B inhibitor ZM447439
during mitotic exit. Dotted mask shows position of DNA in actin channel. Scale bar – 10 µm.
C Quantification of clearance of actin underneath the DNA for stills shown in (B). While actin starts to clear from under the DNA in control cells within 10 min of
forced mitotic exit, it does not clear following Aurora B inhibition.
D Maximum projection of 2 z slices of basal most region of Hela cells stained with Phalloidin at 15 min post-anaphase onset, when cells were treated with DMSO or
ZM447439 during flat monopolar cytokinesis, showing clearance under DMSO treatment and a failure to clear actin with ZM447439 treatment. Dotted mask shows
position of DNA in actin channel. Scale bar = 10 µm.
E Quantification of the fraction of cells undergoing local cortical actin clearance during anaphase based on Phalloidin staining as in (D). With DMSO treatment, 50% of
the cells clear actin completely, whereas the remaining 50% partially clear actin from beneath the DNA (n = 34). Following ZM447439 treatment, only 23% of cells
clear local cortical actin completely, while 73% clear it partially, and there is no clearance in 4% of cells (n = 22 cells). Chi-square test comparing distribution of
cleared vs partial/no clearance shows significant difference between Control DMSO and ZM treatment, P = 0.0413.
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Figure 4. Synergistic effect of Aurora B and centralspindlin during anaphase.
A, B Maximum projection of 2 z slices of representative Hela cells stained for Anillin (A) and pMLC- S19 (B), showing a reduction in these proteins in cells depleted of
centralspindlin protein RACGAP1 that is unaltered upon Aurora B inhibition with ZM. Scale bar = 10 µm.
C Maximum projection of 2 z slices of representative Hela-Cdk1as cells treated with siControl, siRACGAP1, 2 µM ZM and siRACGAP1 with 2 µM ZM, immunostained
with tubulin to visualize spindle midzone at early anaphase and late anaphase. Midzone is specified in siControl and siRACGAP1-treated cells, but fails to be
maintained in siRACGAP1-treated cells at later stages. With ZM treatment, a diffuse midzone persists throughout anaphase. No recognizable midzone is seem in
the double treatment. Scale bar = 10 µm.
D Still images of representative Hela cells expressing LifeAct GFP and H2B-mCherry captured at early anaphase (6min after anaphase onset) under different conditions,
i.e. Control siRNA, knockdown of centralspindlin protein RACGAP1, in the presence and absence of Aurora B kinase inhibitor (2 µMZM). Scale bar = 10 µm.
E Quantification of aspect ratio of cells treated with different conditions as in (D) at 6 min after anaphase onset, before furrow formation. Individually, Aurora B
inhibition and siRACGAP1 have a moderate effect on cell aspect ratio at mitotic exit, while together they have a stronger impact. In the combined treatment,
mitotic cells hardly undergo any elongation and remain spherical until they re-spread sometime later. Ordinary one-way ANOVA with multiple comparison. Each
treatment is compared with siControl, ****P < 0.0001 for all comparisons. Data are represented as box-whisker plot, with box showing 25th–75th percentile values,
whiskers-min to max value and line representing median. Mean  SD for different treatments- siControl (n = 38) – 1.455  0.19, ZM (n = 32) – 1.219  0.16,
siRACGAP1 (n = 25) 1.144  0.078 and siRACGAP1+ZM (n = 16) – 1.013  0.03. Cells for different treatment pooled from n > 3 independent experiments.
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domain, their function may largely reflect their different dynamic
sub-cellular localization (Fu et al, 2009; Li et al, 2015).
How might this function of Aurora B in chromatin-induced
polar relaxation work mechanistically? While much more work
needs to be done, previous work implicated chromosome localized
PP1 and its subunit Sds22 in relaxation of the polar cortical acto-
myosin network through the dephosphorylation of ERM proteins
(Kunda et al, 2012; Rodrigues et al, 2015). This is relevant as PP1
activity and its localization can be regulated by the activity of its
binding partners, and Aurora B has been shown to oppose the
activity of PP1 during mitotic exit by phosphorylating the
conserved binding motif R-V-[S/T]-F in proteins that bind to and
regulate PP1 activity (Nasa et al, 2018). Further, this Aurora B-
dependent phosphorylation of regulatory proteins can lead to
altered PP1 binding. These data lead us to hypothesize that the
change in Aurora B localisation and activity at the metaphase-
anaphase transition facilitates polar relaxation and cytokinesis by
helping to alter the localization and/or activity of the kinetochore
pool of PP1. This is in line with other data that suggest a require-
ment for Aurora B activity at the metaphase-to-anaphase transition,
as blocking Aurora B activity around this transition using INCENP
antibody has a severe effect on actomyosin ring contraction, while
inhibition at a later stage leads to abnormal midbody formation
and defects in abscission (Ahonen et al, 2009). Further, our results
with flat monopolar cytokinesis indicate that proximity of the chro-
matin to the actomyosin network is critical for its relaxation, as the
chromatin-based signal can only relax the actomyosin network
directly underneath it (Fig 3B and C). Thus, Aurora B could indi-
rectly regulate polar relaxation by regulating spindle elongation,
therefore controlling the proximity of the DNA to the cortical acto-
myosin network. Additionally, chromatin bound Aurora B at
mitotic exit could influence polar relaxation through its effects on
timely assembly of a nuclear envelope (Liu & Pellman, 2020),
which would then insulate the poles from the chromatin signal
regulating polar relaxation.
In summary, to generate two cells with an equal complement of
cellular material, multiple events across the cell must be tightly
coordinated in both space and time as cells undergo cytokinesis.
While more remains to be learned about how this is achieved across
systems, our data suggest that dynamic changes in Aurora B (and
the CPC (Landino & Ohi, 2016; Landino et al, 2017)) localization
at anaphase help to stabilize midzone microtubules, promote ingres-
sion of the furrow and trigger timely polar relaxation. In this way,
Aurora B appears to play a key role in the orchestration of mamma-
lian cytokinesis.
Materials and Methods
Cell culture, drug treatments and siRNA treatment
HeLa Kyoto cells, Hela-13 cells (LifeAct GFP, H2B-mCherry)
(Matthews et al, 2012) and Hela-Cdk1as (Ruppert et al, 2018) were
cultured in DMEM (Gibco) supplemented with 10% foetal bovine
serum and penicillin/streptomycin (Gibco) at 37°C and 5% CO2.
hTERT-RPE1 (female) cells (Clontech) were cultured in DMEM
F-12 GlutaMax (Gibco 31331-028), with 10% foetal bovine serum,
3.4% sodium bicarbonate (Gibco 25080-060), 1% Pen-Strep (Gibco
15070-063).
For monopolar cytokinesis, cells were synchronized in prometa-
phase using 5 µM S-trityl-L-cysteine (STLC; Sigma) for 18 h.
Monopolar cytokinesis was initiated by the addition of 20 lM RO-
3306 (Enzo Life Sciences), an inhibitor of Cdk1/CyclinB to STLC-
treated cells. 2 µM ZM447439 (Selleck) and 1 µM AZD1152 (Sel-
leck) were used for Aurora B inhibition and 1 µM of Aurora A inhi-
bitor I (Selleck-S1451) was used for Aurora A inhibition. For
inhibition during monopolar cytokinesis, 2 µM ZM447439 or corre-
sponding drugs were added together with Cdk1 inhibitor.
For siRNA knockdown, HeLa Kyoto, Hela-13, Hela-Cdk1as and
RPE1 cells were transfected with previously published siRNAs using
Lipofectamine RNAiMAX (Invitrogen): RACGAP1 (HSS120934—
Invitrogen), MKLP2 (Hs_KIF20A_5—Qiagen), INCENP (Dharmacon
M-006823-00) and Ect2 (Hs_ECT2_6 FlexiTube siRNA). Following at
least 24 h of transfection, cells were used for imaging or fixed for
◀ Figure 5. Aurora B inhibition affects DNA-dependent actin clearance during anaphase.
A Stills from time-lapse sequence of representative Hela cells expressing LifeAct GFP and H2B-mCherry, exiting mitosis under different conditions, i.e. Control siRNA,
knockdown of centralspindlin protein RACGAP1, in the presence and absence of Aurora B kinase inhibitor (2 µM ZM). Scale bar = 10 µm.
B High magnification view of boxed regions in (A) pseudo-coloured showing failure to reduce actin during anaphase in cells treated with Aurora B inhibitor and even
greater effect with Aurora B inhibitor upon RACGAP1 depletion. Scale bar = 1 µm.
C Quantification of actin intensity at the poles of cells at 6 min post-anaphase onset, before furrow formation under different conditions as in (A). Actin fails to clear
from cell poles upon Aurora B kinase inhibition during mitotic exit and this effect is stronger when both centralspindlin and Aurora B kinase activity are affected,
while polar actin is cleared upon RACGAP1 depletion. Data are represented as mean  SD for treatments—siControl- 0.98  0.05, siRACGAP1 – 0.99  0.04, ZM—
1  0.039, siRACGAP1+ZM—1  0.037. Ordinary one-way ANOVA with multiple comparison- siControl vs siRACGAP1—n.s., P = 0.896, siControl vs ZM—**P = 0.0018,
siControl vs siRACGAP1+ZM—****P < 0.0001 and ZM vs siRACGAP1+ZM—P = 0.1528.
D Schematic representation for quantifying actin intensity profile along the cortex as in (E).
E Quantification of average actin intensity profile for siControl, siRACGAP1, ZM and siRACGAP1+ZM-treated cells shown in (A). While actin levels reduced from the polar
regions in both siControl and siRACGAP1-treated cells seen by levels lower than 1 (dashed red line) in segments 2–8, they failed to be cleared from ZM and
siRACGAP1+ZM treatment conditions. Date are represented as mean  SD.
F Stills of representative Hela cells expressing LifeAct GFP and H2B-mCherry captured at early anaphase under different conditions, i.e. Control siRNA, knockdown of
RACGAP1, in the presence and absence of Aurora B kinase inhibitor (2 µM ZM). The masks below were generated for each cell and the shortest distance between the
centroid of DNA (+) and the masked cortical actomyosin network (*) was quantified in (G) with MATLAB. Scale bar = 10 µm.
G Quantification of shortest distance between centroid of DNA and cortical actomyosin network. While chromatin is able to reach close to the cortex in both siControl
and siRACGAP1-treated cells, the distance of chromatin from cortex increases upon ZM treatment and this distance is further enhanced in the double treatment
condition. Data are represented as mean  SD. siControl—4.7  0.87, siRACGAP1—4.4  0.64, ZM—5.47  0.87, siRACGAP1+ZM—6.35  1.14 lm. Ordinary one-
way ANOVA with multiple comparison, siControl vs ZM, ***P = 0.002, siControl vs siRACGAP1, P = 0.2823, siControl vs siRACGAP1+ZM, ****P < 0.0001, siRACGAP1 vs
siRACGAP1+ZM, ****P < 0.0001, ZM vs siRACGAP1, ****P < 0.0001, ZM vs siRACGAP1+ZM, ***P = 0.0004.
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immunostaining. For Hela-Cdk1as- 2 lM 1NM-PP1 was added to
the medium 2 h after transfection for synchronization. Following an
incubation period of 18 h, cells were washed with media. They were
treated with either DMSO or ZM 2 h after washing and processed
for fixed immunostaining.
Aurora B knock-in cell line
The protocol was adopted from (Lackner et al, 2015). Generic donor
plasmids (Tia1l) were kind gift from Tilmann Burckstummer. We
replaced Turbo-GFP with mNeonGreen(Tia1l_mNeon). gRNA (5’ca
ccGAGAAGGAGAACTCCTACCCC3’) was designed against N-
terminus of human Aurora Kinase B (ENSG00000178999) and
cloned in pX330-U6-Chimeric_BB-CBh-hSpCas9 (addgene 42230)
without any frame shift.
For transfection, lowest passage HeLa cells were seeded in 12-
well dish in antibiotic-free media (DMEM+10%FBS) overnight to get
70–80% confluency. pX330-gRNA (300 ng) and Tia1l_mNeon
(200 ng) were diluted in 75 ll Optimen, incubated for 10 min in
pre-made transfection mix (75 ll optimen + 3.1 ll Lipofectamine
LTX) and applied to cells. Media was replaced next day to complete
media (with antibiotics) and cells were grown for a week. GFP posi-
tive cells were selected by flow cytometry followed by single cell
cloning. Clones were selected by western blotting and localization
was confirmed by live cell imaging.
Live cell imaging
Hela-13 stable cell lines expressing LifeAct GFP and histone2B-
mRFP or RPE1 cells expressing LifeAct, were plated on 4-well
Lab-Tek chamber slides coated with 10 lg/ml fibronectin (Sigma)
at least 12 h before imaging. Cells entering metaphase were
selected and their positions recorded. Following DMSO or 2 µM
ZM447439 addition, cells were re-focussed and images were
acquired every 1 min as cells exited mitosis. For flat monopolar
cytokinesis, Hela-13 cells were plated on Lab-Tek chamber slides.
The following day, they were transfected with pRK5-Rap1[Q63E]
using Lipofectamine 2000 according to the manufacturer’s instruc-
tions.  24 h after transfection, cells were then treated with 5 µM
STLC for 6 h. Cells transfected with Rap1 Q63E were identified by
their failure to round up in prometaphase and were forced to exit
mitosis upon Cdk1 inhibition in presence or absence of Aurora B
inhibitor. Cells were either fixed after 15 min or were imaged
during the exit process.
Immunostaining
Cells were incubated with freshly prepared 4%PFA for 20 min at
room temperature, or ice cold 10% TCA for 20 min. Following
washes with PBS-0.1% Triton, they were incubated with 5%BSAin
PBS as blocking buffer and primary antibody was diluted in 1%
BSA/PBS for overnight at 4C. Following washes, the cells were incu-
bated with secondary antibody and DAPI (and Phalloidin) for 1 h at
room temperature. The slides were mounted with Prolong Gold.
Antibodies used—pERM (Cell Signaling 3726), pMLC (Cell Signaling
3671), RACGAP1 (Everest Biotech), Aurora B (Abcam 2254),




Cells were outlined manually in FIJI from metaphase to 6 min post-
anaphase onset (or till furrow constriction). Timing of anaphase
onset was one frame before any visible DNA separation. The aspect
ratio was obtained in FIJI and the values were normalized to meta-
phase for each cell.
Monopolar cytokinesis
For actin and pERM along the cell–cell outlines were drawn manu-
ally in FIJI on the 2 z slice projection of the midplane region of the
cell. The perimeter was straightened and segmented into 10 equal
domains, which were numbered based on proximity to DNA, 1 and
10 being furthest away, while 5 and 6 being closest to DNA. The
actin/pERM intensity profile along these binned domains was
normalized to the cell average and then plotted with respect to
binned position along cell using PRISM.
Bipolar actin clearance
Polar regions of interest were selected manually on anaphase cells.
The actin intensity was measured from 2 z slice projections of
midplane region, both at anaphase and a similar region of the cell
during metaphase. The relative actin intensity was defined as ratio
of actin anaphase:metaphase for each cell, if value of <1 indicates
that actin has been cleared while > 1 indicates no clearance.
Flat monopolar clearance
DNA signal was used to create a mask, which was replicated in the
LifeAct channel. The actin intensity was measured in this masked
region in the 2 z slice projection from the bottom region of the cell.
Cell outlines were drawn manually and used to determine average
actin intensity in the cell. Relative actin intensity was defined by
normalizing average actin intensity in masked region (underneath
DNA) to average actin intensity in the cell. Value < 1 indicates clear-
ance. For population of cells, we noticed that this ratio was highly
variable, owing to the ranging extent of DNA coming in proximity
with the basal cortex. Therefore, we obtained the median value of
this ratio for the population of cells and classified them as—values
between 1 and median as partial clearance and values less than
median as complete clearance.
DNA-cortex distance measurements
2 z slice projection of the midplane region of cell was used to create
masks for actin (LifeAct) signal with segmentation algorithm in Fiji
and the corresponding masked regions isolated from actin channel.
Using custom MATLAB code, we calculated the shortest distance
from the centroid of each separated DNA to the masked actin chan-
nel at early anaphase.
Line scan plot
A segmented line of width 10 pixels was drawn on the actin cortex from
one equatorial region to the other, encompassing the polar region. 2 z
slice projection of the midplane region of cell was used. Actin intensity
was measured across the entire line using plot prolife function in Fiji.
Values were normalized to metaphase levels for each cell, binned into
10 segments and plotted in Fig 1. For average plots, Fig 5, segmented
line was straightened, divided into 10 bins and average intensity in
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each bin measured. Values were normalized to metaphase levels for
each cell and distribution of cell profiles plotted asmean  SD.
Data availability
This study includes no data deposited in external repositories.
Expanded View for this article is available online.
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